Navigantis Inc. announced today the first successful neurovascular clinical cases performed with its VASCO interventional robotic platform for patients suffering from neurovascular disorders.
Shares of CervoMed Inc. (NASDAQ:CRVO – Get Free Report) have been assigned an average recommendation of “Hold” from the nine ratings firms that are presently covering the stock, MarketBeat.com reports ...